Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0001773751-23-000052 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-07 | 2023-03-03 | HIMS | Dudum Andrew | CEO, Dir, 10% | M - OptEx | $2.43 | +1,249 | 351.9K | +0.4% | +$3,035 |
| D | 2023-03-07 | 2023-03-03 | HIMS | Dudum Andrew | CEO, Dir, 10% | S - Sale+OE | $11.96 | -1,249 | 350.6K | -0.4% | -$14.9K |
| D | 2023-03-07 | 2023-03-03 | HIMS | Dudum Andrew | CEO, Dir, 10% | M - OptEx | $0.00 | -1,249 | 3.21M | -0.0% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-03-03 | M | A | 1,249 | $2.43 | 351,864 | D | — | — | (F1) The option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 3, 2022 by the Reporting Person. |
| 2 | Common | Class A Common Stock | 2023-03-03 | S | D | 1,249 | $11.96 | 350,615 | D | — | — | (F1) The option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 3, 2022 by the Reporting Person. |
| 3 | Derivative | Stock Option (right to buy) | 2023-03-03 | M | D | 1,249 | $0.00 | 3,208,257 | D | $2.43 · — to 2030-06-16 | 1,249 Class A Common Stock | (F2) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. |